Effect of orally administered guanosine on seizures and death induced by glutamatergic agents

Citation
Dr. Lara et al., Effect of orally administered guanosine on seizures and death induced by glutamatergic agents, BRAIN RES, 912(2), 2001, pp. 176-180
Citations number
28
Categorie Soggetti
Neurosciences & Behavoir
Journal title
BRAIN RESEARCH
ISSN journal
00068993 → ACNP
Volume
912
Issue
2
Year of publication
2001
Pages
176 - 180
Database
ISI
SICI code
0006-8993(20010907)912:2<176:EOOAGO>2.0.ZU;2-9
Abstract
Intraperitoneal guanosine has been shown to prevent quinolinic acid-induced seizures in mice. in this study, we investigated the effect of orally admi nistered guanosine on seizures induced by the glutamate agonists quinolinic acid and kainate, and the endogenous glutamate releaser alpha -dendrotoxin . Guanosine (7.5 mg/kg, per os), administered 75 min in advance, prevented 70% of seizures induced by i.c.v. quinolinic acid, being as efficient as th e NMDA channel blocker MK-801 administered intraperitoneally. Guanosine was ineffective against kainate-induced seizures, but significantly reversed t he potentiation of seizures and death caused by the concomitant injection o f MK-801. Guanosine also significantly prevented seizures and death induced by i.c.v. alpha -dendrotoxin, whereas MK-801 and phenobarbital only preven ted death. Altogether, our findings underscore the therapeutic potential of oral administration of guanosine for treating diseases involving glutamate rgic excitotoxicity, including epilepsy. (C) 2001 Elsevier Science B.V. All rights reserved.